Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
ESMO appoints first Chief Medical Officer
ESMO appoints first Chief Medical Officer
New position reflects ESMO’s rapid growth and follows extensive six-month selection process
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Vaccines industry veteran was most recently with MassBiologics
Cypralis hires Dr Michael Peel as Chief Scientific Officer
Cypralis hires Dr Michael Peel as Chief Scientific Officer
He joins the UK life sciences firm from Scynexis, where he was Director of Discovery
Valeant Pharmaceuticals makes management change
Valeant Pharmaceuticals makes management change
In its US Dermatology and Gastrointestinal businesses
Rigel names Anne-Marie Duliege as Chief Medical Officer
Rigel names Anne-Marie Duliege as Chief Medical Officer
Elliott Grossbard retires but will continue advising on NDA filing for fostamatinib
New Chief Medical Officer at Arvinas
New Chief Medical Officer at Arvinas
Angela Shen brings extensive experience in clinical development, medical affairs and business development to the firm
HUYA Bioscience appoints John Ratliff as President and CEO
HUYA Bioscience appoints John Ratliff as President and CEO
He was previously President/COO of Quintiles' Global Services organisation
Onxeo establishes US subsidiary
Onxeo establishes US subsidiary
Pharmaceutical and biotech industry veteran, Philippe Maitre, will head the new venture
Sanofi appoints Dr Yong-Jun Liu as Head of Research
Sanofi appoints Dr Yong-Jun Liu as Head of Research
He will be responsible for leading all of Sanofi's research with the goal of delivering innovative and high-value medicines for patients
Quay Pharma celebrates apprentice success
Quay Pharma celebrates apprentice success
The firm's Apprenticeship Scheme has made an important contribution to the ongoing growth and development of its business
Michael Luther joins Bantam Pharmaceutical as President and CEO
Michael Luther joins Bantam Pharmaceutical as President and CEO
Prior to this he was SVP and General Manager for the Discovery and Development Services Division of Albany Molecular Research
Two executives join Transgene leadership team
Two executives join Transgene leadership team
Maud Brandely and John Felitti join the French firm
Sosei appoints Peter Bains as COO and President elect
Sosei appoints Peter Bains as COO and President elect
He is expected to become Representative Executive Officer, President and Chief Executive at the AGM in June
F-star moves into new facility in Cambridge, UK
F-star moves into new facility in Cambridge, UK
Also expands team with appointment of Michael Davies as VP Protein Sciences
Novavax makes management promotions
Novavax makes management promotions
Also appoints Bob Darius as SVP, Quality Operations
Kymab appoints Dr David Chiswell as Chief Executive
Kymab appoints Dr David Chiswell as Chief Executive
Steps up from interim CEO of the Cambridge, UK-based firm
Previous
1
…
97
98
99
100
(current)
101
102
103
…
213
Next
Trending Articles
MasterControl strengthens executive leadership team with two key appointments
Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all